Singapore - engelsk - HSA (Health Sciences Authority)

dch auriga singapore - gadobenate dimeglumine; gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml; gadobenate dimeglumine 529 mg/ml

Singapore - engelsk - HSA (Health Sciences Authority)

dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml

Singapore - engelsk - HSA (Health Sciences Authority)

dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml

USA - engelsk - NLM (National Library of Medicine)

global isotopes, llc d/b/a zevacor molecular - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c-11 4 mci in 1 ml - choline c11 injection is indicated for positron emission tomography (pet) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (ct) or magnetic resonance imaging (mri). in these patients, 11 c-choline pet imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. suspected prostate recurrence is based upon elevated blood prostate specific antigen (psa) levels following initial therapy. in clinical studies, images were produced with pet/ct coregistration. limitation of use : 11 c-choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer. none. there are no adequate and well controlled studies with choline c11 injection in pregnant women and the fetal radiation dose from a 11 c-choline pet imaging study is unknown. it is not known whether choline c11 injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capa

USA - engelsk - NLM (National Library of Medicine)

washington university school of medicine - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c-11 33.1 mci in 1 ml - choline c 11 injection is indicated for positron emission tomography (pet) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (ct) or magnetic resonance imaging (mri). in these patients, 11 c-choline pet imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. suspected prostate recurrence is based upon elevated blood prostate specific antigen (psa) levels following initial therapy. in clinical studies, images were produced with pet/ct coregistration. limitation of u se: 11 c-choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer. none. pregnancy category c. there are no adequate and well controlled studies with choline c 11 injection in pregnant women and the fetal radiation dose from a 11 c-choline pet imaging study is unknown.  it is not known whether choline c 11 injection can cause f

USA - engelsk - NLM (National Library of Medicine)

curium us llc - sodium pyrophosphate (unii: o352864b8z) (pyrophosphoric acid - unii:4e862e7grq), stannous chloride (unii: 1bqv3749l5) (stannous cation - unii:qi30938bms) - sodium pyrophosphate 11.9 mg in 10 ml - technetium tc 99m pyrophosphate injection is a skeletal imaging agent used to demonstrate areas of altered osteogenesis, and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction. as an adjunct in the diagnosis of confirmed myocardial infarction (ecg and serum enzymes positive), the incidence of false negative images has been found to be 6%. false negative images can also occur if made too early in the evolutionary phase of the infarct or too late in the resolution phase. in a limited study involving 22 patients in whom the ecg was positive and serum enzymes questionable or negative, but in whom the final diagnosis of acute myocardial infarction was made, the incidence of false negative images was 23%. the incidence of false positive images has been found to be 7 to 9%. false positive images have been reported following coronary by-pass graft surgery, in unstable angina pectoris, old myocardial infarcts and in cardiac contusions. technescan pyp is a blood pool imaging agen

USA - engelsk - NLM (National Library of Medicine)

ucsf radiopharmaceutical facility - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c-11 33.1 mci in 1 ml - choline c 11 injection is indicated for positron emission tomography (pet) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (ct) or magnetic resonance imaging (mri). in these patients, 11 c-choline pet imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. suspected prostate recurrence is based upon elevated blood prostate specific antigen (psa) levels following initial therapy. in clinical studies, images were produced with pet/ct coregistration. limitation of u se: 11 c-choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer. none. pregnancy category c. there are no adequate and well controlled studies with choline c 11 injection in pregnant women and the fetal radiation dose from a 11 c-choline pet imaging study is unknown.  it is not known whether choline c 11 injection can cause fetal harm when administered to a pregnant w

USA - engelsk - NLM (National Library of Medicine)

the university of texas md anderson cancer center - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c 11 injection is indicated for positron emission tomography (pet) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (ct) or magnetic resonance imaging (mri). in these patients, 11 c-choline pet imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. suspected prostate recurrence is based upon elevated blood prostate specific antigen (psa) levels following initial therapy. in clinical studies, images were produced with pet/ct coregistration. limitation of use: 11 c-choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer. none pregnancy category c. there are no adequate and well controlled studies with choline c 11 injection in pregnant women and the fetal radiation dose from a 11 c-choline pet imaging study is unknown. it is not known whether choline c 11 injection can cause fetal harm when administered

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - 60724 - medical image management system application software - this viewer is intended to be an accessory used in conjunction with a dmc-ez dicom media creator or similar device which is capable of storing dicom images onto optical discs, magnetic tape or digital memory. the ezdicom cd viewer provides retrieval of dicom images from optical discs, magnetic tape or digital memory and displays these images on computer pc workstations. the display of these images is provided for convenience only and in no way should be used as a basis for determining diagnosis. the ezdicom cd viewer is intended to be an accessory used in conjunction with a dmc-ez dicom media creator or similar device which is capable of storing dicom images onto optical discs, magnetic tape or digital memory. the ezdicom cd viewer provides retrieval of dicom images from optical discs, magnetic tape or digital memory and displays these images on computer pc workstations. the display of these images is provided for convenience only. t

USA - engelsk - NLM (National Library of Medicine)

decatur memorial hospital - choline c-11 (unii: m4as4xgd4q) (choline c-11 - unii:m4as4xgd4q) - choline c11 injection is indicated for positron emission tomography (pet) imaging of patients with suspected prostate cancer recurrence and non-informative bone scintigraphy, computerized tomography (ct) or magnetic resonance imaging (mri). in these patients, 11 c-choline pet imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation. suspected prostate recurrence is based upon elevated blood prostate specific antigen (psa) levels following initial therapy. in clinical studies, images were produced with pet/ct coregistration. limitation of use : 11 c-choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer. none. there are no adequate and well controlled studies with choline c11 injection in pregnant women and the fetal radiation dose from a 11 c-choline pet imaging study is unknown. it is not known whether choline c11 injection can cause fetal harm when administered to a pregnant woman or can affect reproduction capa